Results 31 to 40 of about 1,366 (166)
Acquired sideroblastic anemia, characterized by bone marrow ring sideroblasts (RS), is predominantly associated with myelodysplastic syndrome (MDS). Although somatic mutations in splicing factor 3b subunit 1 (SF3B1), which is involved in the RNA splicing
Tetsuro Ochi +13 more
doaj +1 more source
Lethal ALAS2 Mutation in Males X-Linked Sideroblastic Anaemia
Laurent Pascal +2 more
exaly +2 more sources
X-linked sideroblastic anaemia in a female fetus: a case report and a literature review
Background X-linked sideroblastic anaemia (XLSA) is commonly due to mutations in the ALAS2 gene and predominantly affects hemizygous males. Heterozygous female carriers of the ALAS2 gene mutation are often asymptomatic or only mildly anaemic.
Diane Nzelu +9 more
doaj +1 more source
Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle atrophy, paralysis and even death.
Hualin Sun +10 more
doaj +1 more source
Assignment of human erythroid [delta]-aminolevulinate synthase (ALAS2) to a distal subregion of band Xp11.21 by PCR analysis of somatic cell hybrids containing X;Autosome translocations [PDF]
The erythroid-specific (ALAS2) and housekeeping (ALAS1) genes encoding [delta]-aminolevulinate synthase have recently been mapped to chromosomes Xq21.1-->q21 and 3p21, respectively. The erythroid-specific gene is a candidate for mutations resulting in
Cotter, Philip D. +3 more
core +1 more source
Human 5'-Aminolevulinate Synthase, Erythroid-Specific (ALAS2); A Target Enabling Package
Erythorid specific 5’-Aminolevulinate synthase (ALAS2) catalyses the first and rate-determining step in haem biosynthesis during erythroid development.
Henry J. Bailey (6845153) +13 more
core +2 more sources
Erythroid-specific 5-aminolevulinate synthase (ALAS2) is the rate-limiting enzyme for heme biosynthesis in erythroid cells, and a missense mutation of the ALAS2 gene is associated with congenital sideroblastic anemia.
Kiriko Kaneko +6 more
doaj +1 more source
Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients
Background: The heme biosynthesis (HB) involves eight subsequent enzymatic steps. Erythropoietic protoporphyria (EPP) is caused by loss-of-function mutations in the ferrochelatase (FECH) gene, which in the last HB step inserts ferrous iron into ...
Francesca Granata +9 more
doaj +1 more source
Harnessing large language models (LLMs) for candidate gene prioritization and selection
Background Feature selection is a critical step for translating advances afforded by systems-scale molecular profiling into actionable clinical insights.
Mohammed Toufiq +12 more
doaj +1 more source

